318. Citrin deficiency
[
1 clinical trial,
1 drug（DrugBank:
1 drug),
0 target gene / 0 target pathway ]
Searched query = "Citrin deficiency", "NICCD", "Adult onset type II citrullinemia", "CTLN2"
The queries were searched in Public_title, Scientific_title, and Condition of the data. Export date: 11/21/2019. Trials are sorted by Date_enrolment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollement | Last_Refreshed_ on | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-jRCTs041190017 | 31/07/2012 | 22 July 2019 | Confirmation of effects of medium chain triglyceride therapy for citrin deficiency | Confirmation of effects of medium chain triglyceride therapy for citrin deficiency, especially in patients with symptomatic post neonatal intrahepatic cholestasis and that with adult-onset type II citrullinemia | citrin deficiency Endocrinology and Metabolism, Pediatrics;D006111 | Medium chain triglyceride 5-15ml 3 times a day | Tetsuo Mitsui | Recruiting | 80 age old | Both | 50 | Phase 2 | none |